Optimum Duration of Treatment With 6-Mercaptopurine for Crohn's Disease

Peter Kim, Jusuf Zlatanic, Burton I. Korelitz, Gilbert W. Gleim

The American Journal of Gastroenterology · 1999 · 79 citations · 22 references

Abstract

Discontinuation of 6MP, while Crohn's disease is in remission, leads to higher relapse rates and continuation of 6MP reduces the likelihood of relapse. Therefore, we favor the indefinite use of 6MP once remission has been achieved.

References

22